Savara
SVRA
#5343
Rank
C$1.94 B
Marketcap
C$9.55
Share price
3.66%
Change (1 day)
100.51%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -C$0.17 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$0.14 Billion a decrease over its 2023 earnings that were of -C$75.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.17 Billion23.1%
2024 -C$0.14 Billion75.29%
2023 -C$75.33 Million43.38%
2022 -C$52.54 Million-11.31%
2021 -C$59.24 Million-13.3%
2020 -C$68.32 Million-36.53%
2019 -C$0.11 Billion13.76%
2018 -C$94.63 Million105.54%
2017 -C$46.04 Million34.11%
2016 -C$34.33 Million-37.43%
2015 -C$54.87 Million38.81%
2014 -C$39.53 Million33.62%
2013 -C$29.58 Million38.49%
2012 -C$21.36 Million24.59%
2011 -C$17.15 Million-36.5%
2010 -C$27 Million-3.14%
2009 -C$27.88 Million-23.28%
2008 -C$36.33 Million8.52%
2007 -C$33.48 Million-34.14%
2006 -C$50.84 Million184.43%
2005 -C$17.88 Million90.75%
2004 -C$9.37 Million190.35%
2003 -C$3.23 Million11.64%
2002 -C$2.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-C$25.01 Million-84.30%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-C$0.22 Billion 37.90%๐Ÿ‡บ๐Ÿ‡ธ USA